Literature DB >> 17502360

Cellular targets of interleukin-18 in rheumatoid arthritis.

Sheng-Ming Dai1, Zheng-Zheng Shan, Huji Xu, Kusuki Nishioka.   

Abstract

Recent data are presented which indicate a critical role for interleukin (IL)-18 in rheumatoid arthritis (RA). The T cells and macrophages invading the synovium or in the synovial fluid are the chief cellular targets of IL-18 in RA. Neutrophils, dendritic cells and endothelial cells may also be cellular mediators of IL-18. The direct effect of IL-18 on fibroblast-like synoviocytes or chondrocytes may not be essential or important. In RA, IL-18, which is mainly produced by macrophages, activates T cells and macrophages to produce proinflammatory cytokines, chemokines, adhesion molecules and RANKL which, in turn, perpetuate chronic inflammation and induce bone and cartilage destruction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502360      PMCID: PMC2111635          DOI: 10.1136/ard.2006.067793

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  77 in total

1.  Interleukin-18 acts as an angiogenesis and tumor suppressor.

Authors:  R Cao; J Farnebo; M Kurimoto; Y Cao
Journal:  FASEB J       Date:  1999-12       Impact factor: 5.191

2.  Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity.

Authors:  Christopher E Andoniou; Serani L H van Dommelen; Valentina Voigt; Daniel M Andrews; Geraldine Brizard; Carine Asselin-Paturel; Thomas Delale; Katryn J Stacey; Giorgio Trinchieri; Mariapia A Degli-Esposti
Journal:  Nat Immunol       Date:  2005-09-04       Impact factor: 25.606

3.  Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis.

Authors:  C Plater-Zyberk; L A Joosten; M M Helsen; P Sattonnet-Roche; C Siegfried; S Alouani; F A van De Loo; P Graber; S Aloni; R Cirillo; E Lubberts; C A Dinarello; W B van Den Berg; Y Chvatchko
Journal:  J Clin Invest       Date:  2001-12       Impact factor: 14.808

4.  A proinflammatory role for IL-18 in rheumatoid arthritis.

Authors:  J A Gracie; R J Forsey; W L Chan; A Gilmour; B P Leung; M R Greer; K Kennedy; R Carter; X Q Wei; D Xu; M Field; A Foulis; F Y Liew; I B McInnes
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

5.  Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis.

Authors:  B P Leung; I B McInnes; E Esfandiari; X Q Wei; F Y Liew
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

6.  Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.

Authors:  G Coma; R Peña; J Blanco; A Rosell; F E Borras; J A Esté; B Clotet; L Ruiz; R M E Parkhouse; M Bofill
Journal:  Clin Exp Immunol       Date:  2006-09       Impact factor: 4.330

7.  Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.

Authors:  Leo A B Joosten; Timothy R D Radstake; Erik Lubberts; Liduine A M van den Bersselaar; Piet L C M van Riel; Peter L E M van Lent; Pilar Barrera; Wim B van den Berg
Journal:  Arthritis Rheum       Date:  2003-02

8.  Signal transduction pathways involved in rheumatoid arthritis synovial fibroblast interleukin-18-induced vascular cell adhesion molecule-1 expression.

Authors:  Jacques C M Morel; Christy C Park; Kui Zhu; Pawan Kumar; Jeffrey H Ruth; Alisa E Koch
Journal:  J Biol Chem       Date:  2002-07-08       Impact factor: 5.157

9.  Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.

Authors:  S-M Dai; K Nishioka; K Yudoh
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

10.  Serum interleukin 18 and interleukin 18 binding protein in rheumatoid arthritis.

Authors:  B Bresnihan; P Roux-Lombard; E Murphy; D Kane; O FitzGerald; J-M Dayer
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

View more
  14 in total

1.  Correlation between plasma, synovial fluid and articular cartilage Interleukin-18 with radiographic severity in 33 patients with osteoarthritis of the knee.

Authors:  Youhua Wang; Dawei Xu; Long Long; Xiaolong Deng; Ran Tao; Guicheng Huang
Journal:  Clin Exp Med       Date:  2014-08       Impact factor: 3.984

2.  Inhibitor IkappaBalpha promoter functional polymorphisms in patients with rheumatoid arthritis.

Authors:  Ruei-Nian Li; Yu-Hung Hung; Chia-Hui Lin; Yen-Hsu Chen; Jen-Hsien Yen
Journal:  J Clin Immunol       Date:  2010-06-19       Impact factor: 8.317

3.  Mutual effect between neuropeptides and inflammatory cytokines in neurogenic SMSCs of human temporomandibular joint.

Authors:  Zhi-Ming Liu; You-Jian Peng; Xing Long; Jian Li; Jin Ke; Wei Fang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-08-19

4.  Multiple interleukin-1beta-converting enzymes contribute to inflammatory arthritis.

Authors:  Christian Stehlik
Journal:  Arthritis Rheum       Date:  2009-12

5.  Osteoarthritic Synovial Fluid and TGF-β1 Induce Interleukin-18 in Articular Chondrocytes.

Authors:  Camila B Carballo; Thiago R P Coelho; Rosenilde C de Holanda Afonso; Jane Cristina de Oliveira Faria; Tercia Alves; Samylla M Monte; Grasiella M Ventura Matioszek; Vivaldo Moura-Neto; José M de Brito
Journal:  Cartilage       Date:  2018-08-27       Impact factor: 4.634

6.  Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritis.

Authors:  Xue-Ting Shao; Lei Feng; Li-Juan Gu; Li-Juan Wu; Ting-Ting Feng; Yun-Mei Yang; Nan-Ping Wu; Hang-Ping Yao
Journal:  Clin Exp Med       Date:  2009-02-19       Impact factor: 3.984

7.  Therapeutic effect of low-dose IL-18 combined with IL-10 on collagen-induced arthritis by down-regulation of inflammatory and Th1 responses and induction of Th2 responses.

Authors:  Qiaomei Dai; Yang Li; Fengshan Zhang; Haiyue Yu; Xiaoyan Wang
Journal:  Rheumatol Int       Date:  2008-10-09       Impact factor: 2.631

8.  IL-18 upregulates the production of key regulators of osteoclastogenesis from fibroblast-like synoviocytes in rheumatoid arthritis.

Authors:  Wei Zhang; Xiao-Liang Cong; Yang-Hua Qin; Zheng-Wen He; Dong-Yi He; Sheng-Ming Dai
Journal:  Inflammation       Date:  2013-02       Impact factor: 4.092

9.  Soluble interleukin-18 receptor complex is a novel biomarker in rheumatoid arthritis.

Authors:  Satoko Takei; Tomoaki Hoshino; Kazuko Matsunaga; Yuki Sakazaki; Masanori Sawada; Hanako Oda; Shin-ichi Takenaka; Haruki Imaoka; Takashi Kinoshita; Seiyo Honda; Hiroaki Ida; Taka-aki Fukuda; Hisamichi Aizawa
Journal:  Arthritis Res Ther       Date:  2011-03-24       Impact factor: 5.156

10.  Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells.

Authors:  Richard G Carroll; Carmine Carpenito; Xiaochuan Shan; Gwenn Danet-Desnoyers; Ronghua Liu; Shuguang Jiang; Steven M Albelda; Tatiana Golovina; George Coukos; James L Riley; Zdenka L Jonak; Carl H June
Journal:  PLoS One       Date:  2008-09-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.